Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study

Peter Peichl,Rieke Alten,Mauro Galeazzi,Hanns-Martin Lorenz,H. Nüßlein,Federico Navarro,Yedid Elbez,Melanie Chartier,Roland Hackl,C. Rauch,Sean E. Connolly

Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study

2019

Peter Peichl
Rieke Alten
Mauro Galeazzi
Hanns-Martin Lorenz
H. Nüßlein
Federico Navarro
Yedid Elbez
Melanie Chartier
Roland Hackl
C. Rauch
Sean E. Connolly

Background AbataCepT In rOutiNe clinical practice (ACTION; NCT02109666) was a 2-year international observational study of patients with moderate to severe rheumatoid arthritis.

Keywords:

Pathology
Observational study
Abatacept
Rheumatoid arthritis
Action study
Clinical Practice
Diabetes mellitus
Retention rate
Medicine
Internal medicine
moderate to severe
routine clinical practice
real world data

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations